VITREOUS OPACITIES side effect
What is VITREOUS OPACITIES ?VITREOUS OPACITIES : Avastin Side Effects Report #5498368-0
Health Professional from UNITED KINGDOM reported AVASTIN problem on July 16, 2007. Female patient, 74 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, vitritis, . AVASTIN dosage: 0.04 ML, UNK. Patient recovered.
VITREOUS OPACITIES : Atacand Side Effects Report #5390218-6
ATACAND HCT problem was reported by a Consumer or non-health professional from GERMANY on July 09, 2007. Female patient was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.
VITREOUS OPACITIES : Atacand Side Effects Report #5390218-6
Consumer or non-health professional from GERMANY reported ATACAND HCT problem on July 09, 2007. Female patient was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.
VITREOUS OPACITIES : Atacand Side Effects Report #5415800-9
ATACAND HCT problem was reported by a Physician from GERMANY on Aug 09, 2007. Female patient, weighting 156.5 lb, was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous detachment, vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.
VITREOUS OPACITIES : Lyrica Side Effects Report #5481024-2
Physician from GERMANY reported LYRICA problem on Sept 27, 2007. Male patient, weighting 255.7 lb, was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: vision blurred, visual field defect, vitreous opacities, . LYRICA dosage: unknown. During the same period patient was treated with NEURONTIN, IBUPROFEN. Patient recovered.
VITREOUS OPACITIES : Lucentis Side Effects Report #5503496-7
LUCENTIS problem was reported by a Physician from SWITZERLAND on Oct 17, 2007. Male patient, 75 years of age, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: eye inflammation, visual acuity reduced, vitreous opacities, . LUCENTIS dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVE AGENTS. Patient was hospitalized. Patient recovered.